Investor
Nippon Venture Capital
Independent VC Domestic (Japan)
2026 activity
- 2 tracked 2026 equity round(s)
- Participated in rounds totalling ¥5.32B of equity (plus 1 round(s) with undisclosed or non-equity amounts). This is the sum of whole rounds' equity, including other investors' money; it is not this investor's own investment. Debt is not included.
Amounts are the full announced figure. Grey amounts aren't counted in equity totals. † includes debt, grants or other non-equity (hover for detail).
| Date | Company | Stage | Amount | Investors | Sector |
|---|---|---|---|---|---|
| 3 Jul 2026 | NTNeusignal Therapeutics | Series B | ¥5.32B | Keio Innovation InitiativeNippon Venture CapitalAngel Bridge +4 | Healthcare |
| 23 Jan 2026 | CContrea | Series A | ¥950M† | ITOCHU Technology VenturesAVJSBI Shinsei Corporate Investment +10 | Fintech |